NCIT and the FDA
No drugs, supplements, or any other single product or treatment, especially chemotherapy, radiation, and surgery, can rid the human body of cancer. Self-treatments are dangerous and often deadly.
Cancer is a process that must be dealt with properly. It takes a systematic approach utilizing a variety of technologies to stop the cancer process. That is the process that North Carolina Institute of Technology (NCIT) has developed for breast cancer. NCIT continues to develop technology that will stop all cancers.
NCIT’S only claim is that BREAST CANCER can be cured utilizing the research organization’s technology that has emerged through testing and clinical trials during three decades of study. NCIT guarantees the cure -- something no one else can or is willing to do.
NCIT’s claim, however, is provisional.
NCIT MUST DISCOVER THE BREAST TUMOR USING ITS TECHNOLOGY. It must be obvious that the tumor is too small to have been discovered during traditional breast exams – self-exam, doctor’s exam, or mammography.
Why make such a provision if NCIT has the cure?
The answer may not sound mysterious or glamorous, but it’s the truth. Breast cancer is preventable. Ultimately, that’s what NCIT’s technology is all about. The ultimate cure for cancer is prevention!
NCIT’s technology (Quantum Health Management® or QHM®) can find extremely small cancer masses in the breasts and can find them up to 10 years earlier than mammography.
Furthermore, NCIT research has found the “trigger” for breast cancer, and it’s in the mouth. No exceptions have been found. For women who are proactive with their health, their best course of action is to PREVENT breast cancer.
The next best thing to preventing breast cancer is to discover a breast tumor forming years before other technologies will see it.
It’s no secret. NCIT is proudly promoting its QHM® Labs screening centers as havens of prevention technology for women of all ages.
NCIT’s cure is based on the technology for finding the cancer early and correcting the issues that are now known to trigger breast cancer. The cure at this stage of development can be accomplished in as little as one week which would not significantly delay any other treatment mode should the individual suddenly choose to abandon NCIT technology in favor of traditional chemo, radiation or radical surgery.
Such a disclaimer is only necessary because it does happen. Periodically, women get screened at NCIT and a plan to kill their cancer is provided. These are usually insecure women who have not taken control of their own health. They quickly succumb to a barrage of naysayers, often close family members, in addition to doctors and oncologists who totally discount the idea of viable options.
However, even oncologists agree that when cancer is found early, it is very curable, but NCIT does not agree it is curable with chemotherapy, radiation or radical surgery.
It is NCIT’s position that the Food and Drug Administration (FDA) has a duty to discipline those who make unproven claims just to sell a product. While NCIT is not selling a product, it is making a claim -- a claim that has been substantiated through research and clinical trials.
In fact, NCIT’s claims are documented in a 350-page book about the technology, and an entire chapter in the book is devoted to an “unprecedented public challenge.”
In the matter of products, whether they are pharmaceutical or alternative supplements, if reliable studies are not available to give credence to the claims, then the product should be removed from the market.
The purpose of the FDA is to help protect the public from fraudulent claims and actions that can cause the loss of money, bodily harm or prevent the use of technology that has some real or imagined validity, such as traditional chemotherapy, radiation or radical surgery.
NCIT’s stand on these traditional treatments is that if they were effective for the majority of the population, then they should continue without interference. Statistics are very clear, however, that the effectiveness of these treatments is disturbingly LOW.
NCIT has QHM® Labs screening facilities in North Carolina and Arizona. Screening centers are already planned for all 50 states, plus Canada and several foreign countries.
These screening labs are equipped with technology for the very early identification of cancer and many degenerative diseases. All labs utilize FDA-cleared technology. These laboratories hold both state and federal licenses. It is NCIT’S policy to make every effort to comply with all laws and regulations.
What now? Contact NCIT? More INFO?
